Tag: Genomics

Uri Tabori

Staff Physician, Haematology/Oncology & Senior Scientist, Genetics & Genome Biology, The Hospital for Sick Children; Senior Scientist, The Hospital for Sick Children; Garron Family Chair in Childhood Cancer Research   Full Biography   Cancers of Interest Brain, Gastrointestinal stromal tumours (GIST), Head and Neck   Research Interests and Clinical Approach The Tabori lab is focused… Read more »

Sheila Singh

Professor of Surgery and Biochemistry, McMaster University; Chief Pediatric Neurosurgeon, McMaster Children’s Hospital; Division Head, Neurosurgery, Hamilton Health Sciences Director, McMaster Centre for Discovery in Cancer Research Senior Canada Research Chair, Human Brain Cancer Stem Cell Biology Director, McMaster Surgeon Scientist Program   Full Biography   Cancers of Interest Brain   Projects at BioCanRx Bispecific… Read more »

Sachdev Sidhu

Professor, Donnelly Centre, University of Toronto   Full Biography   Cancers of Interest Bladder, Blood, Brain, Breast, Colorectal, Gastric, Head and Neck, Kidney, Liver, Lung, Neuroblastoma, Ovarian, Pancreatic, Prostate, Skin   Research and clinical approaches The Sidhu lab studies the relationships between protein structure and function, using phage display in conjunction with high-throughput screening and… Read more »

Harman Sekhon

Chief, Division of Anatomic Pathology, Ottawa Hospital; Regional Head and Director of Anatomic Pathology, Eastern Ontario Regional Laboratory Association (EORLA); Regional Cancer Pathology Lead, Cancer Care Ontario (CCO)   Full Biography   Cancers of Interest Lung Ovarian Prostate   Projects at BioCanRx Interrogation of Biomarkers in Patient Samples from a Phase Ib Trial of the… Read more »

Trevor Pugh

Senior Scientist, Princess Margaret Cancer Centre Canada Research Chair in Translational Genomics Associate Professor, Department of Medical Biophysics, University of Toronto Director, Translational Genomics Laboratory, Ontario Institute for Cancer Research   Full Biography   Cancers of Interest Blood, Brain, Breast, Cervical, Colorectal, Endometrial, Gynecologic, Head and Neck, Kidney, Liver, Lung, Neuroblastoma, Ovarian, Pediatric solid tumours

Claude Perreault

Principal Investigator, Immunobiology Research Unit, IRIC Professor, Department of Medicine, Faculty of Medicine, Université de Montréal   Full Biography   Cancers of Interest Blood Breast Lung Ovarian   Projects at BioCanRx DEVELOPING T CELLS THAT TARGET ANTIGENS SPECIFIC TO LYMPHOID CANCERS   Recent Articles Research Management Committee

Brad Nelson

Scientific Co-Director, BC Cancer Immunotherapy Program (Deeley Research Centre) Professor of Biochemistry/Microbiology, University of Victoria Professor of Medical Genetics, University of British Columbia   Full Biography   Projects at BioCanRx Enabling a Phase I/II Multicenter Clinical Trial of a Novel Single Domain (sd)CD-22-specific Camelid-derived Chimeric Antigen Receptor (CAR) T-cell Therapy   Interrogation of Biomarkers in… Read more »

Karen Mossman

Professor, Pathology and Molecular Medicine, McMaster University Vice President, Research, McMaster University   Full Biography   Cancers of Interest Breast Cancer   Projects at BioCanRx In vivo genome-wide CRISPR/Cas9 screen to identify genes that limit curative checkpoint blockade immunotherapy in triple negative breast cancer   Recent Articles I study viruses: How our team isolated the… Read more »

Scott McComb

Research Officer, National Research Council; Adjunct Professor, Department of Biochemistry, Microbiology, and Immunology, University of Ottawa   Full Biography   Cancers of Interest Blood Colorectal Lung Ovarian   Projects at BioCanRx Clinical Trial Enabling Studies for Multi-targeted Chimeric Antigen Receptor Therapeutics for the Treatment of B-Cell Malignancies

Aly-Khan Lalani

Assistant Professor, Oncology, McMaster University   Full Biography   Cancers of Interest Bladder Gastrointestinal Stromal Tumours (GIST) Genitourinary Kidney Prostate Soft Tissue Sarcoma Testicular   Projects at BioCanRx   Phase II CYTOSHRINK Trial: Cytoreductive Stereotactic Hypofractionated Radiotherapy with Combination Ipilimumab and Nivolumab for Metastatic Kidney Cancer